10x Genomics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
10x Genomics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • 10x Genomics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$35.8M, a 61.6% increase year-over-year.
  • 10x Genomics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$183M, a 18.3% increase year-over-year.
  • 10x Genomics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$255M, a 53.7% decline from 2022.
  • 10x Genomics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$166M, a 185% decline from 2021.
  • 10x Genomics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$58.2M, a 89.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$255M -$89.1M -53.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 -$166M -$108M -185% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 -$58.2M +$485M +89.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$543M -$511M -1637% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 -$31.3M +$81.2M +72.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 -$112M -$93.7M -500% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$18.8M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.